When was BBi-Biotech founded?

BBi-Biotech was founded in 2008.

Where is BBi-Biotech located?

BBi-Biotech is headquartered in Berlin, Germany.

How many employees does BBi-Biotech have?

As of May 31, 2026, the latest employee count at BBi-Biotech is 10.

Is BBi-Biotech a funded company?

BBi-Biotech is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does BBi-Biotech rank among its competitors?

BBi-Biotech ranks 1936th amongst 1956 active competitors, of which 452 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Antheia, which secured $24M in Jan, 2026.

Who are the top competitors of BBi-Biotech?

BBi-Biotech's top competitors include Synthego, Antheia and Transcenta. Among them, Antheia secured the most recent funding round in January, 2026.

BBi-Biotech - 2026 Company Profile & Competitors

BBi-Biotech is an unfunded company based in Berlin (Germany), founded in 2008. It operates as a Develops fermentors and bioreactors. BBi-Biotech has not raised any funding yet. The company has 1956 active competitors, including 452 funded and 333 that have exited. Its top competitors include companies like Synthego, Antheia and Transcenta.

Company Details

BBi-Biotech engages in manufacturing equipment for industrial biotechnology application and offers services in research applications in pharmaceutical, food, cosmetic and biotech sector. The product portfolio of the company includes cell culture bioreactors, automated sample handling systems, and accessories for reactors and fermentors.

Website: bbi-biotech.com
Email ID: *****@bbi-biotech.com

Key Metrics

Founded Year

2008

Location

Berlin, Germany

Stage

Unfunded

Ranked

1936^th among 1956 active competitors

Employee Count

10 as on May 31, 2026

Similar Companies

Synthego & 2665 more

View BBi-Biotech's full profile

BBi-Biotech has not raised any funding rounds yet.

BBi-Biotech's employee count trend

BBi-Biotech has 10 employees as of May 26. Here is BBi-Biotech's employee count trend over the years:

Uncover BBi-Biotech's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of BBi-Biotech include Synthego, Antheia and Transcenta. Here is the list of Top 10 competitors of BBi-Biotech, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Synthego 2012, Redwood City (United States), Acquired	Developer of CRISPR-engineered cell and gene therapies	$460M	8VC, Perceptive Advisors & 30 others	71/100
2nd	Antheia 2013, Palo Alto (United States), Series C	Genetically engineered yeast cells to produce medicinal products	$176M	Viking Global Investors, ATHOS KG & 15 others	67/100
3rd	Transcenta 2019, Suzhou (China), Public	Developer of antibody-based therapeutics	$205M	Lilly Asia Ventures, Temasek & 11 others	66/100
4th	Judges Scientific 2002, London (United Kingdom), Public	Acquisition and development of scientific instrument businesses	-	Origin Capital, Lloyds Banking Group	65/100
5th	Akeso 2012, Zhongshan (China), Public	Developer of antibody drug conjugates for the treatment of broad spectrum diseases	$195M	Orbimed, Sino Biopharmaceutical & 18 others	65/100
6th	Korro Bio 2018, Cambridge (United States), Public	Provider of RNA editing technologies to develop genetic medicines for rare and prevalent diseases	$4M	Cormorant Asset Management, Fidelity Investments ... & 14 others	64/100
7th	Fermentalg 2005, Libourne (France), Public	Innovating with algae for sustainable solutions in nutrition and environmental impact	$30.3M	Demeter, Bpifrance & 14 others	63/100
8th	Microban 1994, Huntersville (United States), Acquired	Antimicrobial and odor control technologies for durable product protection and freshness	$64.6M	UBS, Brown Brothers Harriman & 1 others	63/100
9th	Dewpoint Therapeutics 2018, Boston (United States), Series D	Developer of small molecule based therapeutics	$346M	Maverick Ventures, Polaris Partners & 16 others	62/100
10th	One Biosciences 2020, Paris (France), Series A	Developer of single-cell therapeutics solutions to treat multiple health disorders	$22.4M	BLAST Premier, Redmile Group & 6 others	62/100
1936th	BBi-Biotech 2008, Berlin (Germany), Unfunded	Develops fermentors and bioreactors	-	-	20/100